PortfoliosLab logoPortfoliosLab logo
EW vs. EZJ
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

EW vs. EZJ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Edwards Lifesciences Corporation (EW) and ProShares Ultra MSCI Japan (EZJ). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, EW achieves a 3.04% return, which is significantly lower than EZJ's 22.21% return. Both investments have delivered pretty close results over the past 10 years, with EW having a 9.56% annualized return and EZJ not far ahead at 9.82%.


EW

1D
0.65%
1M
-0.84%
6M
3.96%
YTD
3.04%
1Y
15.37%
3Y*
-1.76%
5Y*
-3.86%
10Y*
9.56%

EZJ

1D
-3.75%
1M
-5.92%
6M
9.65%
YTD
22.21%
1Y
59.09%
3Y*
23.02%
5Y*
7.83%
10Y*
9.82%
*Multi-year figures are annualized to reflect compound growth (CAGR)

EW vs. EZJ - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
EW
Edwards Lifesciences Corporation
3.04%15.16%-2.91%2.20%-42.41%42.00%17.32%52.31%35.90%20.29%
EZJ
ProShares Ultra MSCI Japan
22.21%42.72%3.31%30.78%-38.23%-1.96%22.21%33.76%-30.99%49.10%

Correlation

The correlation between EW and EZJ is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.21

Correlation (3Y)
Calculated over the trailing 3-year period

0.26

Correlation (5Y)
Calculated over the trailing 5-year period

0.35

Correlation (10Y)
Calculated over the trailing 10-year period

0.34

Correlation (All Time)
Calculated using the full available price history since Jun 5, 2009

0.31

The correlation between EW and EZJ shifts across timeframes, from 0.21 (1 year) to 0.35 (5 years), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

EW vs. EZJ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EW
EW Risk / Return Rank: 6464
Overall Rank
EW Sharpe Ratio Rank: 6666
Sharpe Ratio Rank
EW Sortino Ratio Rank: 6060
Sortino Ratio Rank
EW Omega Ratio Rank: 5757
Omega Ratio Rank
EW Calmar Ratio Rank: 6969
Calmar Ratio Rank
EW Martin Ratio Rank: 7070
Martin Ratio Rank

EZJ
EZJ Risk / Return Rank: 5050
Overall Rank
EZJ Sharpe Ratio Rank: 4949
Sharpe Ratio Rank
EZJ Sortino Ratio Rank: 4747
Sortino Ratio Rank
EZJ Omega Ratio Rank: 5050
Omega Ratio Rank
EZJ Calmar Ratio Rank: 5555
Calmar Ratio Rank
EZJ Martin Ratio Rank: 5050
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

EW vs. EZJ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Edwards Lifesciences Corporation (EW) and ProShares Ultra MSCI Japan (EZJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


EWEZJDifference
Sharpe ratioReturn per unit of total volatility

-0.77

Sortino ratioReturn per unit of downside risk

-0.86

Omega ratioGain probability vs. loss probability

1.12

1.26

-0.13

Calmar ratioReturn relative to maximum drawdown

1.21

2.22

-1.01

Martin ratioReturn relative to average drawdown

2.97

6.62

-3.65

EW vs. EZJ - Sharpe Ratio Comparison

The current EW Sharpe Ratio is 0.62, which is lower than the EZJ Sharpe Ratio of 1.40. The chart below compares the historical Sharpe Ratios of EW and EZJ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

EW vs. EZJ - Drawdown Comparison

The maximum EW drawdown since its inception was -54.32%, smaller than the maximum EZJ drawdown of -58.63%. Use the drawdown chart below to compare losses from any high point for EW and EZJ.


Loading charts...

Drawdown Indicators


EWEZJDifference

Max Drawdown

Largest peak-to-trough decline

-54.32%

-58.63%

+4.31%

Max Drawdown (1Y)

Largest decline over 1 year

-12.73%

-26.78%

+14.05%

Max Drawdown (3Y)

Largest decline over 3 years

-37.53%

-31.48%

-6.05%

Max Drawdown (5Y)

Largest decline over 5 years

-54.32%

-58.63%

+4.31%

Max Drawdown (10Y)

Largest decline over 10 years

-54.32%

-58.63%

+4.31%

Current Drawdown

Current decline from peak

-32.78%

-11.38%

-21.40%

Average Drawdown

Average peak-to-trough decline

-14.54%

-21.19%

+6.65%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.19%

8.95%

-3.76%

Volatility

EW vs. EZJ - Volatility Comparison

The current volatility for Edwards Lifesciences Corporation (EW) is 8.03%, while ProShares Ultra MSCI Japan (EZJ) has a volatility of 14.72%. This indicates that EW experiences smaller price fluctuations and is considered to be less risky than EZJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


EWEZJDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.03%

14.72%

-6.69%

Volatility (6M)

Calculated over the trailing 6-month period

19.66%

34.89%

-15.23%

Volatility (1Y)

Calculated over the trailing 1-year period

24.86%

42.57%

-17.71%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

32.76%

37.24%

-4.48%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

32.26%

34.70%

-2.44%

Dividends

EW vs. EZJ - Dividend Comparison

EW has not paid dividends to shareholders, while EZJ's dividend yield for the trailing twelve months is around 1.94%.


PositionTTM20252024202320222021202020192018
EW
Edwards Lifesciences Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EZJ
ProShares Ultra MSCI Japan
1.94%1.13%2.09%1.11%0.56%0.00%0.00%0.24%4.49%

Frequently Asked Questions


EW and EZJ have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

EZJ has higher volatility (14.72%) compared to EW (8.03%). In terms of maximum drawdown, EW dropped -54.32% vs EZJ's -58.63%.

EZJ currently has the higher Sharpe Ratio (1.40 vs 0.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for EW and EZJ

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer